The hepatitis B vaccine can prevent liver cancer

Worldwide, up to 80% of liver cancer and hepatitis B virus infection in China, 71 percent of liver cancer by the hepatitis B evolved. Professor Zhang Meihui-based research, the World Health Organization (WHO) that hepatitis B vaccine is the only vaccine that can prevent primary liver cancer and hepatitis B vaccine to prevent hepatitis B is most effective, safe and economical method.

Hepatitis B vaccine in the prevention of mother to child transmission, Professor Zhang Meihui: with HBsAg positive is the highest risk mothers and their infants is most difficult to prevent the success rate in the small-scale clinical trials in the past when everyone can reach more than 90% of the benefits of prevention, but wait until the comprehensive implementation of his achievements did not like the small-scale so well, generally statistics seem, the whole look something about Eighty - five, then the HBsAg-negative mother and negative mother gives birth to a child, he is very good, small-scale study looks close to 100% can be prevented success, the entire large-scale look close to 100 percent, but they really produce the antibody status of not so high, means they are probably there may be almost about 5% of the children does not really produce a good antibody response.

Strengthening the crowd outside the neonatal hepatitis B vaccination

In 1992, China's Ministry of Health hepatitis B vaccine into children's immunization management, and promulgated the "National Hepatitis B vaccine immunization plan"; 2002, the State Council approved the hepatitis B vaccine into children's immunization of children in large cities since the hepatitis B surface antigen (HBsAg) carrier rate is significantly reduced. HBsAg carriers to reduce the number of 20 million. However, the whole of hepatitis B surface antigen carrier rate has not decreased significantly, particularly relative to the World Health Organization on the global hepatitis B control goal is still a considerable gap. Ministry of Health in 2005 hepatitis B as AIDS, tuberculosis, schistosomiasis focus on control of infectious diseases. Proposed on the basis of further improve neonatal immunization in people that are outside the neonatal hepatitis B vaccination strategies.